Related Experiment Video
Updated: Sep 27, 2026
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Adenovirus-mediated gene transfer to the transplanted piglet heart after intracoronary injection
Frank Griscelli1, Emre Belli, Paule Opolon
1UMR 1582, Vectorologie et Transfert de Gènes, Institut Gustave Roussy, PR2, 39 rue Camille Desmoulins, Villejuif, France. grisceli@igr.fr
Background:
The advent of cardiac gene therapy in clinical practice requires a more efficient and safer myocardial gene delivery in large animals. A new approach to adenovirus-mediated intracoronary gene transfer in the piglet, using a heterotopic heart transplantation model, was designed to maximize the duration of contact between the vector and the heart in noncoronary flow conditions.
Methods:
Recombinant adenoviruses harboring a nucleus-localized beta-galactosidase gene under the control of a viral promoter were injected into the coronary vessels of the harvested hearts at a dose ranging from 10(10) to 2 x 10(11) pfu. The graft was maintained for 75 min in saline solution and then implanted in the abdomen of recipients. Gene transfer to allografts was evaluated 4 days after grafting by immunohistochemical and enzymatic analysis of beta-galactosidase expression.
Results:
Transgene expression was detected in all cardiac areas and up to 64, 44, 32, and 15% of positive nuclei were estimated in the left ventricle wall in four animals out of eleven. In the remaining animals, transgene expression was focally distributed, mainly in the left ventricle wall. PCR analysis revealed the presence of adenoviral sequences, albeit minimal, in exposed organs such as the liver and lung.
Conclusions:
This procedure demonstrated that direct intracoronary gene transfer can be achieved using an ex vivo gene transfer strategy.
